RWK BidCo AB, a newly formed company indirectly wholly owned by KKR Funds, has announced a recommended public offer to the shareholders of Biotage to tender all ordinary shares in Biotage to RWK BidCo at a price of SEK 145 in cash per ordinary share.
For more information, please refer to RWK BidCo AB’s website relating to the offer, www.bio-offer.com.
The Board of Directors of Biotage has announced its statement relating to the offer pursuant to section II.19 of the Nasdaq Stockholm takeover rules and recommends the shareholders of Biotage to accept the offer. The recommendation in its entirety is available below.
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage
Biotage är ett Globalt Go-To Separations-företag, som stödjer kunder inom forskning och tillverkning av läkemedel, diagnostik och analytiska tester, med intelligenta och hållbara arbetsflödeslösningar. Vår expertis och våra högkvalitativa separationslösningar spelar en nyckelroll för att effektivisera kunders arbetsflöden och förbättra deras resultat. Biotage har sitt huvudkontor i Sverige, 700 medarbetare globalt, och levererar lösningar till över 80 länder. Vårt företag är noterat på NASDAQ Stockholm (BIOT).
Copyright © 2020 Biotage
SEL-2EV
Two Channel, Extended Collection Bed, UV Detector